20
Samsung Biologics Co.,Ltd.
207940.KS · KSC
₩1,414,000.00 -0.63% (-₩9,000.00)
1M -8.13%
Market Cap ₩65.9T
P/E Ratio 33.20x
Div. Yield -
ROE 20.27%
Piotroski F-Score Strong
8/9Valuation
12 /100
Expensive P/FCF 45.15x
P/E 33.20x
P/B 8.31x
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
96 /100
Strong Op. margin 43.70%
Gross margin 39.66%
FCF margin 32.09%
Quality
80 /100
Excellent ROA 16.54%
ROIC 15.42%
Asset turnover 0.38x
Debt
98 /100
Low Int. coverage 135.37x
Debt/Equity 0.15x
Net debt/EBITDA 0.24x
Stability
0 /100
Unstable Beta 0.20x
Profitable years N/A
Rev. volatility N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 207940.KS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Chongbo Rim
Employees
5,455
Headquarters
Incheon
Evenimente viitoare
27 OCT.
Earnings
Upcoming earnings report